Formula | C3H5O2S |
MW | 105.13 |
InChIKey | HGTBAIVLETUVCG-KFOLPBEONA-M |
Entry_Date | 2023-09-01 |
Net_Charge | -1 |
Number_Atoms | 12 |
Number_Heavy_Atoms | 6 |
Number_Rings | 0 |
Number_Bonds | 11 |
Rotat_Bonds | 3 |
Unbranched_Chain | 3 |
Chiral_Centers | 0 |
ONatoms | 2 |
HB_Donor | 1 |
HB_Acceptor | 2 |
OpenEye_HB_Donors | 0 |
OpenEye_HB_Acceptors | 2 |
Lipinski_HB_Donors | 0 |
Lipinski_HB_Acceptors | 2 |
Lipinski_Violations | 0 |
XLogP3 | 0 |
XLogP | 0.46 |
logP | 0.434 |
PSA | 62.6 |
MR | 25.8978 |
ABS | 0.85 |
Solubility | very |
Aggregator | Pass |
PM7_Heat_of_Formation_kcal_per_mol | -121.25986 |
PM7_Total_Energy_ev | -1205.25573 |
PM7_Electronic_Energy_ev | -4037.70802 |
PM7_Dipole_Debye | 9.53955 |
PM7_Point_Group | Cs |
PM7_HOMO_Energy_ev | -4.633 |
PM7_LUMO_Energy_ev | 3.899 |
PM7_COSMO_Area_square_ang | 133.55 |
PM7_COSMO_Volue_cubic_ang | 122.23 |
PM7_Electron_Affinity_ev | -3.899 |
PM7_Ionization_Energy_ev | 4.633 |
PM7_Energy_Gap_ev | 8.532 |
PM7_Global_Hardness_ev | 4.266 |
PM7_Global_Softness_ev | 0.23441162681669012 |
PM7_Chemical_Potential_ev | -0.367 |
PM7_Electronigativity_ev | 0.367 |
PM7_Back_Donation_Energy_ev | -1.0665 |
PM7_Electrophilicity_ev | 0.015786333802156587 |
OPENEYE_Name | 2-methylsulfanylacetate |
SMILES | C(=O)(CSC)[O-] |
Canonical_SMILES | CSCC(=O)O |
InChI | 1/C3H6O2S/c1-6-2-3(4)5/h2H2,1H3,(H,4,5)/p-1/fC3H5O2S/q-1 |
InChI_3D | 1S/C3H6O2S/c1-6-2-3(4)5/h2H2,1H3,(H,4,5) |
AuxInfo | 1/1/N:2,3,1,4,5,6/E:(4,5)/F:m/E:m/rA:11nCCCO-OSHHHHH/rB:;s1;s1;d1;s2s3;s2;s2;s2;s3;s3;/rC:;-1.5,-2.5981,0;-.5,-.866,0;-.5,.866,0;1,0,0;-1,-1.7321,0;-1.067,-2.8481,0;-1.933,-2.3481,0;-1.75,-3.0311,0;-.067,-1.116,0;-.933,-.616,0; |
Duplicates | DB03517 |
mol2_Path | /CCDB/DrugBank/Database/Compound-0000000000-0000049999/Compound-0000003500-0000003749/DB03517.mol2 |
pdbqt_Path | /CCDB/DrugBank/Database/Compound-0000000000-0000049999/Compound-0000003500-0000003749/DB03517.pdbqt |
sdf_Path | /CCDB/DrugBank/Database/Compound-0000000000-0000049999/Compound-0000003500-0000003749/DB03517.sdf |